UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Chemical Society reviews, ISSN 0306-0012, 11/2013, Volume 42, Issue 23, pp. 887 - 8894
Physical Sciences | Chemistry | Chemistry, Multidisciplinary | Science & Technology | Selenocysteine - metabolism | Selenomethionine - metabolism | Reactive Oxygen Species - metabolism | Humans | Neoplasms - prevention & control | Selenium Compounds - metabolism | Clinical Trials as Topic | Histone Deacetylase Inhibitors - chemistry | Selenoproteins - metabolism | Selenomethionine - therapeutic use | Selenoproteins - chemistry | Cystine - metabolism | Cystine - therapeutic use | Sulfhydryl Compounds - chemistry | Selenocysteine - therapeutic use | Histone Deacetylase Inhibitors - metabolism | Selenocysteine - analogs & derivatives | Cystine - analogs & derivatives | Dietary Supplements | Selenium Compounds - therapeutic use | Organoselenium Compounds - metabolism | Organoselenium Compounds - therapeutic use | Index Medicus | Selenium compounds | Pathways | Medical services | Selenium | Biological | Metabolism | Chemical compounds | Speciation
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2009, Volume 301, Issue 1, pp. 39 - 51
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Humans | Middle Aged | Male | Neoplasms - prevention & control | Treatment Outcome | Prostatic Neoplasms - epidemiology | Selenomethionine - therapeutic use | Selenium - therapeutic use | alpha-Tocopherol - therapeutic use | Antioxidants - therapeutic use | Vitamin E - therapeutic use | Aged | Prostatic Neoplasms - prevention & control | Dietary Supplements | Neoplasms - epidemiology | Disease prevention | Clinical trials | Selenium | Vitamin E | Prostate cancer | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Expert opinion on drug delivery, ISSN 1742-5247, 06/2011, Volume 8, Issue 6, pp. 749 - 763
intratumoral drug delivery | antiangiogenic therapy | selenomethionine | tumor vascular normalization | methylselenocysteine | interstitial fluid pressure | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Cysteine - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Organoselenium Compounds - administration & dosage | Angiogenesis Inhibitors - pharmacology | Organoselenium Compounds - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Neoplasms - drug therapy | Cysteine - administration & dosage | Drug Synergism | Angiogenesis Inhibitors - administration & dosage | Animals | Cysteine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cysteine - adverse effects | Cysteine - pharmacology | Angiogenesis Inhibitors - therapeutic use | Organoselenium Compounds - adverse effects | Selenocysteine - analogs & derivatives | Angiogenesis Inhibitors - adverse effects | Organoselenium Compounds - therapeutic use | Selenium compounds | Clinical trials | Cytotoxicity | Data processing | Drug delivery | Malignancy | Survival | Metastases | antiangiogenic agents | Chemotherapy | Side effects | Antitumor agents | Cancer | Tumors | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 04/2004, Volume 10, Issue 7, pp. 2561 - 2569
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Tumors | Cysteine - analogs & derivatives | Neoplasm Transplantation | Carcinoma, Squamous Cell - metabolism | Humans | Antineoplastic Agents - therapeutic use | Colonic Neoplasms - metabolism | Organoselenium Compounds - pharmacology | Dose-Response Relationship, Drug | Time Factors | Cysteine - pharmacology | Female | Antineoplastic Agents - pharmacology | Selenocysteine - analogs & derivatives | Camptothecin - analogs & derivatives | Selenium - chemistry | Selenomethionine - pharmacology | Administration, Oral | Radiation-Sensitizing Agents - pharmacology | Neoplasms - drug therapy | Drug Synergism | Selenium - therapeutic use | Maximum Tolerated Dose | Animals | Carcinoma, Squamous Cell - drug therapy | Mice, Nude | Cell Line, Tumor | Mice | Camptothecin - pharmacology | Index Medicus
Journal Article
Nutrition and cancer, ISSN 0163-5581, 07/2011, Volume 63, Issue 5, pp. 778 - 789
Oncology | Life Sciences & Biomedicine | Nutrition & Dietetics | Science & Technology | Fundamental and applied biological sciences. Psychology | Feeding. Feeding behavior | Biological and medical sciences | Vertebrates: anatomy and physiology, studies on body, several organs or systems | Cysteine - analogs & derivatives | Male | Neoplasm Proteins - chemistry | Gene Expression Profiling | Neoplasm Proteins - metabolism | RNA, Messenger - metabolism | Prostate - metabolism | Selenomethionine - therapeutic use | Gene Expression Regulation - drug effects | Xenograft Model Antitumor Assays | Animals | Cysteine - therapeutic use | Mice, Nude | Prostate - drug effects | Protein Biosynthesis - drug effects | Mice | Mice, Inbred BALB C | Prostatic Neoplasms - prevention & control | Proteomics - methods | Selenocysteine - analogs & derivatives | Selenium Compounds - therapeutic use | Organoselenium Compounds - therapeutic use | Anticarcinogenic Agents - therapeutic use | Sodium Selenite - therapeutic use | Proteins | Selenium | Prostate cancer | Rodents | Index Medicus
Journal Article
Cancer prevention research (Philadelphia, Pa.), ISSN 1940-6207, 05/2009, Volume 2, Issue 5, pp. 484 - 495
Life Sciences & Biomedicine | Oncology | Science & Technology | In Situ Nick-End Labeling | Cysteine - analogs & derivatives | Prostatic Neoplasms - pathology | Adenocarcinoma - pathology | Enzyme-Linked Immunosorbent Assay | Apoptosis - drug effects | Male | Mice, Transgenic | Antineoplastic Agents - therapeutic use | Insulin-Like Growth Factor I - drug effects | Adenocarcinoma - drug therapy | Blotting, Western | Selenomethionine - therapeutic use | Animals | Cysteine - therapeutic use | Cell Proliferation - drug effects | Mice | Selenocysteine - analogs & derivatives | Organoselenium Compounds - therapeutic use | Prostatic Neoplasms - drug therapy | Index Medicus | synaptophysin | methylselenol precursor compounds | prostate cancer | transgenic mice
Journal Article
Placenta (Eastbourne), ISSN 0143-4004, 2012, Volume 33, Issue 12, pp. 1012 - 1019
Internal Medicine | Obstetrics and Gynecology | Antioxidants | Oxidative stress | Reactive oxygen species | Trophoblast | Selenium | Life Sciences & Biomedicine | Developmental Biology | Obstetrics & Gynecology | Reproductive Biology | Science & Technology | Fundamental and applied biological sciences. Psychology | Embryology: invertebrates and vertebrates. Teratology | Biological and medical sciences | Oxidants - pharmacology | Oxidative Stress | Glutathione Peroxidase - antagonists & inhibitors | Humans | Protective Agents - metabolism | Protective Agents - chemistry | Protective Agents - therapeutic use | Selenomethionine - therapeutic use | Trophoblasts - drug effects | Pre-Eclampsia - prevention & control | Sodium Selenite - metabolism | Osmolar Concentration | Sodium Selenite - antagonists & inhibitors | Enzyme Induction - drug effects | Female | Auranofin - pharmacology | Cell Line | Glutathione Peroxidase - metabolism | Selenium - chemistry | Selenomethionine - antagonists & inhibitors | Selenomethionine - metabolism | Trophoblasts - metabolism | Enzyme Inhibitors - pharmacology | Thioredoxin Reductase 2 - antagonists & inhibitors | Thioredoxin Reductase 2 - genetics | Glutathione Peroxidase - genetics | Pregnancy | Selenium - therapeutic use | Thioredoxin Reductase 2 - metabolism | Selenium - metabolism | Thioredoxin Reductase 1 - antagonists & inhibitors | Thioredoxin Reductase 1 - genetics | Dietary Supplements | Sodium Selenite - therapeutic use | Thioredoxin Reductase 1 - metabolism | Index Medicus
Journal Article
British journal of nutrition, ISSN 0007-1145, 06/2008, Volume 101, Issue 2, pp. 182 - 189
Metabolism and Metabolic Studies | L-Selenomethionine | Tumour-derived cells | Cellular apoptosis | Organic selenium derivatives | Methyl-L-selenocysteine | Life Sciences & Biomedicine | Nutrition & Dietetics | Science & Technology | Fundamental and applied biological sciences. Psychology | Feeding. Feeding behavior | Biological and medical sciences | Vertebrates: anatomy and physiology, studies on body, several organs or systems | Cysteine - analogs & derivatives | Neuroectodermal Tumors, Primitive, Peripheral - pathology | Adenocarcinoma - pathology | Skin Neoplasms - drug therapy | Apoptosis - drug effects | Colonic Neoplasms - drug therapy | Epithelial Cells - drug effects | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Selenomethionine - therapeutic use | Carcinoma, Hepatocellular - drug therapy | Adult | Female | Liver Neoplasms - pathology | Carcinoma - pathology | Selenocysteine - analogs & derivatives | Organoselenium Compounds - therapeutic use | Anticarcinogenic Agents - therapeutic use | Carcinoma - drug therapy | Skin Neoplasms - pathology | Cell Survival | Liver Neoplasms - drug therapy | Epithelial Cells - pathology | Melanoma - pathology | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Animals | Cysteine - therapeutic use | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Melanoma - drug therapy | Adolescent | Carcinoma, Hepatocellular - pathology | Cell Line, Tumor | Selenium Compounds - therapeutic use | Neuroectodermal Tumors, Primitive, Peripheral - drug therapy | Index Medicus
Journal Article